|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with SERCA2 x DNA x ATP2A1
100 Translational Medicine associated with SERCA2 x DNA x ATP2A1
0 Patents (Medical) associated with SERCA2 x DNA x ATP2A1